vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Hour Loop, Inc (HOUR). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $56.1M, roughly 1.5× Hour Loop, Inc). BillionToOne, Inc. runs the higher net margin — 6.8% vs -1.2%, a 8.0% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 3.0%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $3.0M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Hour Loop, Inc. is an e-commerce retail company that offers a diverse portfolio of products including home goods, apparel, toys, electronics accessories, and daily consumer essentials. It primarily operates through leading third-party online marketplaces, with its core customer base concentrated in North America, focusing on delivering affordable, high-value daily products to mass consumers.
BLLN vs HOUR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $56.1M |
| Net Profit | $5.7M | $-657.3K |
| Gross Margin | 69.9% | 49.6% |
| Operating Margin | 11.5% | -1.5% |
| Net Margin | 6.8% | -1.2% |
| Revenue YoY | 117.4% | 3.0% |
| Net Profit YoY | 138.3% | 57.0% |
| EPS (diluted) | $0.10 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $56.1M | ||
| Q3 25 | $83.5M | $33.4M | ||
| Q2 25 | — | $27.1M | ||
| Q1 25 | — | $25.8M | ||
| Q4 24 | — | $54.4M | ||
| Q3 24 | $38.4M | $31.1M | ||
| Q2 24 | — | $28.1M | ||
| Q1 24 | — | $24.7M |
| Q4 25 | — | $-657.3K | ||
| Q3 25 | $5.7M | $530.6K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $654.5K | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-14.9M | $469.6K | ||
| Q2 24 | — | $649.1K | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | 49.6% | ||
| Q3 25 | 69.9% | 51.4% | ||
| Q2 25 | — | 57.2% | ||
| Q1 25 | — | 54.7% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | 52.6% | 54.8% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 58.6% |
| Q4 25 | — | -1.5% | ||
| Q3 25 | 11.5% | 2.2% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | — | -4.5% | ||
| Q3 24 | -32.9% | 2.3% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 6.2% |
| Q4 25 | — | -1.2% | ||
| Q3 25 | 6.8% | 1.6% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | -38.8% | 1.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 4.3% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $0.10 | $0.01 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.02 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-1.47 | $0.01 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | — |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $7.0M |
| Total Assets | $327.5M | $23.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.9M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $7.0M | ||
| Q3 25 | $-239.5M | $7.7M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | $-242.9M | $6.7M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | — | $23.8M | ||
| Q3 25 | $327.5M | $31.6M | ||
| Q2 25 | — | $23.0M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $32.4M | ||
| Q2 24 | — | $20.2M | ||
| Q1 24 | — | $16.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $3.0M |
| Free Cash FlowOCF − Capex | $6.5M | $3.0M |
| FCF MarginFCF / Revenue | 7.7% | 5.3% |
| Capex IntensityCapex / Revenue | 8.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | $13.8M | $500.4K | ||
| Q2 25 | — | $-901.5K | ||
| Q1 25 | — | $-23.9K | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-2.2M | ||
| Q2 24 | — | $456.2K | ||
| Q1 24 | — | $492.9K |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $6.5M | $449.3K | ||
| Q2 25 | — | $-901.6K | ||
| Q1 25 | — | $-24.6K | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-2.2M | ||
| Q2 24 | — | $439.4K | ||
| Q1 24 | — | $475.1K |
| Q4 25 | — | 5.3% | ||
| Q3 25 | 7.7% | 1.3% | ||
| Q2 25 | — | -3.3% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | 2.8% | ||
| Q3 24 | — | -7.0% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 8.8% | 0.2% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | 0.94× | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | -0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -4.64× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
HOUR
Segment breakdown not available.
